AUTL
Autolus Therapeutics
AUTL
AUTL
69 hedge funds and large institutions have $169M invested in Autolus Therapeutics in 2021 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4.29% more ownership
Funds ownership: 33.82% → 38.11% (+4.3%)
Holders
69
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$18.1M | |
| 2 | +$15.2M | |
| 3 | +$11.9M | |
| 4 |
Goldman Sachs
New York
|
+$4.24M |
| 5 |
SCM
Sio Capital Management
New York
|
+$3.93M |
Top Sellers
| 1 | -$13M | |
| 2 | -$12.3M | |
| 3 | -$12.1M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$2.65M |
| 5 |
BlackRock
New York
|
-$1.61M |